Impact of common thrombophilias and JAK2 V617F on pregnancy outcomes in unselected Italian women

Journal of Thrombosis and Haemostasis

Volumn 9, Issue 3, 2011, Pages 496-501

  Grandone, E ^a   Colaizzo, D ^a   Tiscia, G ^a   Vergura, P ^a   Cappucci, F ^a   Greco, L ^b   Margaglione, M ^c   Martinelli, P ^b  

^a CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c UNIVERSITY OF FOGGIA   (Italy)

Author keywords

Inherited thrombophilia; JAK2; Pregnancy

Indexed keywords

BLOOD CLOTTING FACTOR 5 LEIDEN; JANUS KINASE 2; PROTHROMBIN;

ADOLESCENT; ADULT; ARTICLE; FEMALE; GENETIC MARKER; GENOTYPE; HETEROZYGOTE; HUMAN; ITALY; MAJOR CLINICAL STUDY; MUTATIONAL ANALYSIS; NEWBORN; POLYMERASE CHAIN REACTION; PREECLAMPSIA; PREGNANCY OUTCOME; PREGNANT WOMAN; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SINGLE NUCLEOTIDE POLYMORPHISM; SMALL FOR DATE INFANT; SOMATIC MUTATION; STILLBIRTH; THROMBOPHILIA;

ADOLESCENT; ADULT; AMINO ACID SUBSTITUTION; COHORT STUDIES; FACTOR V; FEMALE; HETEROZYGOTE; HUMANS; INFANT, NEWBORN; INFANT, SMALL FOR GESTATIONAL AGE; ITALY; JANUS KINASE 2; MIDDLE AGED; MUTATION, MISSENSE; PREGNANCY; PREGNANCY COMPLICATIONS, HEMATOLOGIC; PREGNANCY OUTCOME; PROSPECTIVE STUDIES; PROTHROMBIN; RISK FACTORS; THROMBOPHILIA; YOUNG ADULT;

EID: 79952049503     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2011.04183.x     Document Type: Article

References (33)

1. Kocher O, Cirovic C, Malynn E, Rowland CM, Bare LA, Young BA, Henslee JG, Laffler TG, Huff JB, Kruskall MS, Wong G, Bauer KA. Obstetric complications in patients with hereditary thrombophilia identified using the LCx microparticle enzyme immunoassay: a controlled study of 5, 000 patients. Am J Clin Pathol 2007; 127: 68-75.
2. Rey E, Kahn SR, David M, Shrier I. Thrombophilic disorders and foetal loss: a meta-analysis. Lancet 2003; 361: 901-8.
3. Kovalevsky G, Gracia CR, Berlin JA, Sammel MD, Barnhart KT. Evaluation of the association between hereditary thrombophilias and recurrent pregnancy loss: a meta-analysis. Arch Intern Med 2004; 164: 558-63.
4. Kosmas IP, Tatsioni A, Ioannidis JP. Association of Leiden mutation in factor V gene with hypertension in pregnancy and pre-eclampsia: a meta-analysis. J Hypertens 2003; 21: 1221-8.
5. Dudding TE, Attia J. The association between adverse pregnancy outcomes and maternal factor V Leiden genotype: a meta-analysis. Thromb Haemost 2004; 9: 700-11.
6. Rodger MA, Betancourt MT, Clark P, Lindqvist PG, Dizon-Townson D, Said J, Seligsohn U, Carrier M, Salomon O, Greer IA. The association of factor V leiden and prothrombin gene mutation and placenta-mediated pregnancy complications: a systematic review and meta-analysis of prospective cohort studies. PLoS Med 2010; 7: e1000292.
7. Grandone E, Tomaiuolo M, Colaizzo D, Ames PR, Margaglione M. Role of thrombophilia in adverse obstetric outcomes and their prevention using antithrombotic therapy. Semin Thromb Hemost 2009; 35: 630-43.
8. Clark P, Walker ID, Govan L, Wu O, Greer IA. The GOAL study: a prospective examination of the impact of factor V Leiden and ABO[H] blood groups on haemorrhagic and thrombotic pregnancy outcomes. Br J Haematol 2008; 140: 236-40.
9. Middeldorp S, van de Poel MH, Bank I, Hamulyák K, Libourel EJ, Koopman MMW, Prins MH, van der Meer J, Buller HR. Unselected women with elevated levels of factor VIII:C or homocysteine are not at increased risk for obstetric complications. Thromb Haemost 2004; 92: 787-90.
10. Silver RM, Zhao Y, Spong CY, Sibai B, Wendel G Jr, Wenstrom K; Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Foetal Medicine Units (NICHD MFMU) Network. Prothrombin gene G20210A mutation and obstetric complications. Obstet Gynecol 2010;115:14-20.
11. Baxter EJ, Scott LM, Campbell PJ, East C, Fourouclas N, Swanton S, Vassiliou GS, Bench AJ, Boyd EM, Curtin N, Scott MA, Erber WN, Green AR; Cancer Genome Project. Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders. Lancet 2005; 365: 1054-61.
12. Grandone E, Colaizzo D, Tiscia GL, Vergura P, Chinni E, Iannaccone L, Antinolfi I, Guardascione MA, Margaglione M. Venous thrombosis in oral contraceptive users and the presence of the JAK2 V617F mutation. Thromb Haemost 2008; 99: 640-2.
13. Griesshammer M, Struve S, Barbui T. Management of Philadelphia negative chronic myeloproliferative disorders in pregnancy. Blood Rev 2008; 22: 235-45.
14. Passamonti F, Randi ML, Rumi E, Pungolino E, Elena C, Pietra D, Scapin M, Arcaini L, Tezza F, Moratti R, Pascutto C, Fabris F, Morra E, Cazzola M, Lazzarino M. Increased risk of pregnancy complications in patients with essential thrombocythemia carrying the JAK2 (617V>F) mutation. Blood 2007; 110: 485-9.
15. Xu X, Zhang Q, Luo J, Xing S, Li Q, Krantz SB, Fu X, Zhao ZJ. JAK2 (V617F): prevalence in a large Chinese hospital population. Blood 2007; 109: 339-42.
16. Jones AV, Kreil S, Zoi K, Waghorn K, Curtis C, Zhang L, Score J, Seear R, Chase AJ, Grand FH, White H, Zoi C, Loukopoulos D, Terpos E, Vervessou EC, Schultheis B, Emig M, Ernst T, Lengfelder E, Hehlmann R, et al. Widespread occurrence of the JAK2 V617F mutation in chronic myeloproliferative disorders. Blood 2005; 106: 2162-8.
17. Passamonti F, Rumi E, Pietra D, Lazzarino M, Cazzola M. JAK2 (V617F) mutation in healthy individuals. Br J Haematol 2007; 136: 678-9.
18. Mercier E, Lissalde-Lavigne G, Gris JC. JAK2 V617F mutation in unexplained loss of first pregnancy. N Engl J Med 2007; 357: 1984-5.
19. Dahabreh IJ, Jones AV, Voulgarelis M, Giannouli S, Zoi C, Alafakis-Tzannatos C, Varla-Leftherioti M, Moutsopoulos HM, Loukopoulos D, Fotiou S, Cross NC, Zoi K. No evidence for increased prevalence of JAK2 V617F in women with a history of recurrent miscarriage. Br J Haematol 2009; 144: 802-3.
20. Colaizzo D, Tiscia GL, Pisanelli D, Bafunno V, Amitrano L, Grandone E, Guardascione MA, Margaglione M. New TET2 gene mutations in patients with myeloproliferative neoplasms and splanchnic vein thrombosis. J Thromb Haemost 2010; 8: 1142-4.
21. American College of Obstetricians and Gynecologists Committee on Obstetric Practice. ACOG practice bulletin, number 33, January 2002. Diagnosis and management of preeclampsia and eclampsia. American College of Obstetricians and Gynecologists. Int J Gynecol Obstet 2002;77:67-75.
22. Parazzini F, Cortinovis I, Bortolus R, Fedele L, Recarli A. Weight at birth by gestational age in Italy. Hum Reprod 1995; 10: 1862-3.
23. Martinelli P, Grandone E, Colaizzo D, Paladini D, Scianname N, Margaglione M, Di Minno G. Familial thrombophilia and the occurrence of foetal growth restriction. Haematologica 2001; 86: 428-31.
24. Said JM, Higgins JR, Moses EK, Walker SP, Borg AJ, Monagle PT, Brennecke SP. Inherited thrombophilia polymorphisms and pregnancy outcomes in nulliparous women. Obstet Gynecol 2010; 115: 5-13.
25. Warren JE, Simonsen SE, Branch DW, Porter TF, Silver RM. Thromboprophylaxis and pregnancy outcomes in asymptomatic women with inherited thrombophilias. Am J Obstet Gynecol 2009; 200: 281.e1-5.
26. Coppens M, Folkeringa N, Teune MJ, Hamulyuk K, van der Meer J, Prins MH, Buller HR, Middeldorp S. Outcome of the subsequent pregnancy after a first loss in women with the factor V Leiden or prothrombin 20210A mutations. J Thromb Haemost 2007; 5: 1444-8.
27. Lissalde-Lavigne G, Fabbro-Peray P, Cochery-Nouvellon E, Mercier E, Ripart-Neveu S, Balducchi J-P, Daures JP, Perneger T, Querè I, Dauzat M, Mares P, Gris JC. Factor V Leiden and prothrombin G20210A polymorphisms as risk factors for miscarriage during a first intended pregnancy: the matched case-control 'NOHA first' study. J Thromb Haemost 2005; 3: 2178-84.
28. Warburton D, Strobino B. Recurrent spontaneous abortion. In: Bennet MJ, Edmonds DK, eds. Spontaneous and Recurrent Abortion. Oxford: Blackwell Scientific, 1987: 77-89.
29. Grandone E, Colaizzo D, Tiscia G, Margaglione M. More on: factor V Leiden and prothrombin G20210A polymorphisms as risk factors for miscarriage during a first-intended pregnancy: the matched case-control 'NOHA first' study. J Thromb Haemost 2006; 4: 709-10.
30. Stirrat GM. Recurrent miscarriage I: definition and epidemiology. Lancet 1990; 336: 673-5.
31. Lussana F, Dentali F, Abbate R, d'Aloja E, D'Angelo A, De Stefano V, Faioni EM, Grandone E, Legnani C, Martinelli I, Simioni P, Tormene D; Italian Society for Haemostasis and Thrombosis. Screening for thrombophilia and antithrombotic prophylaxis in pregnancy: guidelines by the Italian Society of Haemostasis and Thrombosis. Thromb Res 2009;124:e19-25.
32. Bogdanova N, Horst J, Chlystun M, Croucher PJ, Nebel A, Bohring A, Todorova A, Schreiber S, Gerke V, Krawczak M, Markoff A. A common haplotype of the annexin A5 (ANXA5) gene promoter is associated with recurrent pregnancy loss. Hum Mol Genet 2007; 16: 573-8.
33. Tiscia G, Colaizzo D, Chinni E, Pisanelli D, Sciannamè N, Favuzzi G, Margaglione M, Grandone E. Haplotype M2 in the annexin A5 (ANXA5) gene and the occurrence of obstetric complications. Thromb Haemost 2009; 102: 309-13.